United States · FDA National Drug Code directory
Fluticasone Propionate and Salmeterol
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0093-3607_7d5ea703-6c3d-4ae3-be5e-a923b8c9cc21
- Product NDC
- 0093-3607
- Form
- POWDER, METERED
- Composition / generic term
- Fluticasone Propionate and Salmeterol
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20170428
- Source listing expiry
- 20271231
Source-listed ingredients
- FLUTICASONE PROPIONATE — 55 ug/1
- SALMETEROL XINAFOATE — 14 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 POUCH in 1 CARTON (0093-3607-82) / 1 INHALER in 1 POUCH / 60 POWDER, METERED in 1 INHALER · 0093-3607-82
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →